Advertise on podcast: Health Longevity Secrets

Elizabeth Holmes went to prison for promising hundreds of blood tests from a single drop of your finger. Some of what she promised is now FDA cleared, and some of it may never be possible at all. With the new documentary You Can See Everything in theaters, Robert Lufkin MD looks at what Theranos promised, what really happened, what is actually FDA cleared in 2026, the physics of a single drop, and which home and finger-stick tests you can trust. Watch the video: https://youtu.be/CjpbudYdV1I Sources - U.S. SEC, Theranos, CEO Holmes, and Former President Balwani Charged With Massive Fraud (Mar 14, 2018): https://www.sec.gov/newsroom/press-releases/2018-41 - U.S. Attorney's Office, N.D. Cal., U.S. v. Elizabeth Holmes, et al.: https://www.justice.gov/usao-ndca/us-v-elizabeth-holmes-et-al - DOJ, Elizabeth Holmes Sentenced To More Than 11 Years For Defrauding Theranos Investors (Nov 18, 2022): https://www.justice.gov/usao-ndca/pr/elizabeth-holmes-sentenced-more-11-years-defrauding-theranos-investors-hundreds - Walgreens, Walgreens Terminates Relationship with Theranos (2016): https://corporate.walgreens.com/news-and-stories/press-releases/2016/walgreens-terminates-relationship-with-theranos-will-be-closing-operations-at-all-40-theranos-wellness-centers-in-arizona/ - AP, Feds ban Theranos CEO Holmes from running lab for 2 years (2016): https://apnews.com/general-news-16add2a7397b47cca3e8bb463e037526 - FDA 510(k) K230391, BD MiniDraw SST (cleared Dec 1, 2023): https://www.accessdata.fda.gov/cdrh_docs/pdf23/K230391.pdf - FDA 510(k) K230493, BD MiniDraw H&H: https://www.accessdata.fda.gov/cdrh_docs/reviews/K230493.pdf - FDA 510(k) K221131, Tasso+ (cleared Aug 12, 2022): https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221131.pdf - FDA, FDA Clears First Over-the-Counter Continuous Glucose Monitor (Mar 5, 2024): https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor - Bond MM, Richards-Kortum RR. Drop-to-Drop Variation in the Cellular Components of Fingerprick Blood. Am J Clin Pathol 2015;144:885-894: https://doi.org/10.1309/AJCP1L7DKMPCHPEH - Jacobsen LM et al. Accuracy of Three Commercial Home-Use Hemoglobin A1c Tests. Diabetes Technol Ther 2022;24(11):789-796: https://doi.org/10.1089/dia.2022.0187 - You Can See Everything (A24, 2026), AP coverage: https://apnews.com/article/nathan-fielder-elizabeth-holmes-documentary-film-premiere-cc89d956b120a0f7035d044e4c6bb3d6 Visual credits - Product images (Part 5): Theranos miniLab, Fig. 2A from Nourse MB et al., Bioeng Transl Med 2018;3(1):58-70, PMC5773944, CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), cropped; Tasso+ image: Tasso, Inc. (tassoinc.com); Stelo image: Dexcom (stelo.com); BD MiniDraw image: BD (Becton, Dickinson and Company) press release, Dec 7, 2023. Company images used with credit; trademarks belong to their owners. - Article card (Part 5): headline and abstract excerpt from Jacobsen LM et al., Diabetes Technol Ther 2022;24(11):789-796, doi:10.1089/dia.2022.0187 - Screen captures of U.S. government pages (SEC, U.S. Department of Justice, FDA press announcement, FDA 510(k) letters K230391 and K221131) are U.S. government works in the public domain. - Charts, timeline, checklist and the fingertip-drop animation are original graphics by Robert Lufkin MD, drawn from the sources above. - Film excerpts: You Can See Everything (A24, 2026), dir. Nathan Fielder and Lance Oppenheim. Short clips from the Official Trailer (https://www.youtube.com/watch?v=HvW_N5p1q44) and Official Teaser (https://www.youtube.com/watch?v=GGJSRFWALTI), used for commentary and criticism. Not affiliated with or endorsed by A24 or the filmmakers. Photo: Max Morse for TechCrunch, CC BY 2.0, via Wikimedia Commons (cropped/edited). Educational content only. This is not medical advice. Talk with your own healthcare provider before making changes to your health. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

A young scientist died in a Russian plague lab. Officials deny an accident. Is biowarfare a real threat, or is the bigger risk something else? Robert Lufkin MD looks at the death of a young lab worker at Russia's Irkutsk anti-plague institute, why Moscow's denials are hard to take at face value, and what Annie Jacobsen's book Biological War: A Scenario gets right and wrong. Untreated pneumonic plague is almost always fatal. The right antibiotics cut deaths sharply. A strain that shrugs off those drugs is the real nightmare. Historically, the bigger risk has been accidents, secrecy, and a slow response, not a deliberate attack. Chapters: 00:00 — Introduction 00:41 — What Happened at the Irkutsk Plague Lab 01:54 — Why the World Doesn't Take Russia's Word 03:09 — Satellite Images of Russia's Expanding Biolabs 03:25 — Annie Jacobsen's Biological War Scenario 04:48 — Untreated Plague Is Almost Always Fatal 05:31 — Madagascar's Drug-Resistant Plague Strain 05:50 — Lab Accidents Are More Likely Than Attacks 06:29 — The 2019 Fire at Russia's Vector Lab 06:48 — The Takeaway: Chronic Disease Was the Real Risk Key takeaways: A young scientist died of pneumonia of unknown origin at a Siberian plague lab. Independent reports alleged a broken tube of live plague. Russian authorities deny a lab accident. In 1979, spores leaked from a Soviet military bioweapons facility. Moscow blamed bad meat for 13 years. Satellite images show 10 new buildings and more than 250,000 square feet added at a Russian biological facility since 2022. Untreated pneumonic plague is almost always fatal. In a CDC review, antibiotics cut deaths to about 17 percent with the right drugs. In 1995, doctors in Madagascar found a plague strain resistant to every antibiotic then recommended. Lab accidents, secrecy, and slow response have been the larger historical risk, including a 2019 fire at the Vector lab. In the COVID data cited here, nearly 95 percent of hospitalized adults already had a chronic condition. Studies & sources: Nelson et al., Clinical Infectious Diseases, 2020 Galimand et al., New England Journal of Medicine, 1997 Kompaniyets et al., Preventing Chronic Disease, 2021 CNN, October 4, 2026 The Atlantic on the 1979 Sverdlovsk anthrax leak Washington Post on Russia's laboratory expansion The Conversation on Annie Jacobsen, Biological War: A Scenario CNN on the 2019 Vector lab fire Dr. Lufkin's book Lies I Taught in Medical School. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

She lived to 117 — and when scientists sequenced everything from her genome to her gut bacteria, they found a paradox that rewrites what aging has to look like. In this episode, Robert Lufkin MD breaks down the landmark multiomics study of Maria Branyas Morera, the world's oldest verified person, published in Cell Reports Medicine (2025) by the Esteller lab. The study mapped her genome, epigenome, proteome, metabolome, and microbiome — and found a body that was simultaneously very old and biologically young. Chapters: 00:00 — Introduction00:43 — Who Was Maria Branyas Morera, the World's Oldest Person?01:18 — The Multiomics Study Published in Cell Reports Medicine02:03 — The Paradox: Old and Young at the Same Time02:23 — Epigenetic Clocks: A Biological Age 23 Years Younger02:51 — Why Her Short Telomeres May Have Protected Her03:44 — Clean Metabolism: Very Low Triglycerides, High HDL04:22 — Inflammaging: Why Low Inflammation Is the Real Headline05:10 — Gut Microbiome, Daily Yogurt, and Bifidobacterium06:05 — The Longevity Chain: Gut, Inflammation, Metabolism06:23 — The Honest Caveat: Half Genetics, Half Lifestyle07:29 — The Takeaway: What Aging Cleanly Really MeansKey takeaways: Six epigenetic clocks estimated her biological age as much as 23+ years younger than her chronological ageHer telomeres were among the shortest recorded in a healthy person — possibly acting as a brake on tumor growth rather than a death sentenceHer lipid panel was remarkably clean: extremely low VLDL and triglycerides, very high HDLSystemic inflammation stayed strikingly low — "inflammaging" was turned downHer gut microbiome was unusually diverse and dominated by Bifidobacterium — she ate about three yogurts a day for the last 20 years of her lifeIt's an n-of-1 study: roughly half genetics, half lifestyle — but the pattern points upstream to metabolic healthStudies & sources mentioned: Santos-Pujol et al., Cell Reports Medicine 2025 — The multiomics blueprint of the individual with the most extreme lifespanWatch the video version on YouTube: https://youtu.be/0TX_E46sAFk 📖 Dr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ 📰 Substack newsletter: https://robertlufkinmd.substack.com 🌐 Website: https://robertlufkinmd.com ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

A facial plastic surgeon reveals the MRI data on "Ozempic face," why repeated masseter Botox can thin the jawbone, and the topical rapamycin resetting skin cells to a 20-year-old phenotype. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with Dr. Kay Durairaj, a USC and UCLA-trained facial plastic surgeon bringing evidence-based medicine to the longevity-aesthetics frontier. Old friends from their UCLA head and neck tumor-board days, they dig into the science most aesthetic clinics gloss over: how GLP-1 drugs uniquely strip facial fat, why exosomes and peptides are a "Wild West," the surprising data on retinoids and epigenetic aging, and how collagen biostimulators and topical rapamycin may genuinely rejuvenate skin at the cellular level. Chapters: 00:00 — Introduction02:03 — From Head & Neck Cancer Surgery to Longevity Aesthetics03:04 — Bringing Evidence-Based Medicine to the Aesthetics Wild West04:06 — Why Aging Should Be Treated as a Disease06:07 — Ozempic Face: The MRI Data on Facial Fat Loss09:14 — The Mid-Face Miracle Protocol: Collagen Biostimulators10:15 — Reversing Ozempic Face After Rapid Weight Loss11:15 — Exosomes Explained: Real Biology vs Marketing Hype14:18 — How to Vet Exosome Sourcing, Purity and Shelf Life16:22 — The Peptide Wild West: BPC-157, SS-31 and FDA-Approved Options19:28 — N-of-1 Peptide Risks: Angiogenesis and Oncogenes20:28 — Do Retinoids Accelerate Aging? The MitraBio Epigenetic Data23:32 — Sculptra and Radiesse: Real Regenerative Science25:33 — Masseter Botox and Permanent Jawbone Thinning29:37 — Three Facial Biomarkers of Biological Age31:38 — Does Lifting Weights Help or Hurt Your Face?36:48 — Topical Rapamycin: Resetting Fibroblasts to a 20-Year-Old40:51 — A New Peptide Skin-Longevity Line and Final AdviceKey takeaways: GLP-1 drugs uniquely attack facial fat — MRI data show roughly 7% midfacial volume loss for every 10 kg of weight lost, primarily from superficial and deep cheek fat pads, driving "Ozempic face."Collagen biostimulators (like Sculptra and Radiesse) can preserve or restore facial volume during rapid weight loss and have 20+ years and 200+ peer-reviewed papers behind their collagen-remodeling effects.The exosome and research-peptide markets are largely unregulated — source, purity, shelf life, and donor quality matter, and lyophilized "exosome" skincare is often just protein fragments.Repeated masseter Botox can thin the mandibular bone, especially in postmenopausal women — animal data are consistent, human data are mixed, so caution is warranted with aggressive long-term use.Topical rapamycin (a "rapalog") may reset the fibroblast mTOR cycle, shifting aged, bloated skin cells toward a younger, spindle-shaped phenotype — an emerging frontier in cellular skin rejuvenation.Studies & sources: Radiographic Midfacial Volume Changes in Patients on GLP-1 Agonists (7% loss per 10 kg) — https://pubmed.ncbi.nlm.nih.gov/40407186/Soft Tissue Facial Changes Following Massive Weight Loss, Aesthetic Surgery Journal Open Forum 2024 — https://pmc.ncbi.nlm.nih.gov/articles/PMC11427949/MitraBio epigenetic skin DNA-methylation tape-strip profiling — https://mitrabio.tech/resources/unlocking-epigenetic-insights/Repeated botulinum toxin masseter injections decrease mandibular angle bone volume — https://pmc.ncbi.nlm.nih.gov/articles/PMC5466904/RapaLogic / Re-Q topical rapalog for fibroblast skin rejuvenation — https://www.rapamycin.news/t/a-new-rapalog-for-skin-aging-rapalogix-health-rlx-201/22010GHK-Cu copper peptide: regenerative and protective actions in skin — https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/Dr. Kay Durairaj — Beauty by Dr. Kay — https://beautybydrkay.com/📖 Dr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Will AI cure all disease? 90% of biomedical papers published in December 2025 show signs of AI assistance — and the Nobel laureate behind AlphaFold says AI could help end all disease within a decade. In this episode, Robert Lufkin MD examines what artificial intelligence is really doing to health science: the quiet takeover of the scientific paper, the first AI-discovered drug to pass a Phase 2a trial, robot laboratories running experiments around the clock, and the honest caveats behind the "end of disease" headlines — plus what it all means for your health today. Chapters: 00:00 — The 90% Stat: AI Fingerprints in Biomedical Papers 00:49 — Part 1: The Quiet Takeover of the Scientific Paper 02:16 — Part 2: The Wins Are Real 02:46 — AlphaFold, 200 Million Proteins & the 2024 Nobel Prize 03:13 — Rentosertib: First AI-Discovered Drug to Pass Phase 2a 04:02 — The Superbug Puzzle: 10 Years vs 2 Days 04:22 — Part 3: Robot Labs & the 10-Year Promise 05:26 — Demis Hassabis on "The End of Disease" 06:26 — Part 4: The New Bottleneck Is Verification 07:43 — Part 5: The Honest Caveats 08:42 — Part 6: The Takeaway Key takeaways: Roughly 90% of biomedical papers published in December 2025 show measurable signs of AI writing assistance — most of it polishing, not fraud. AlphaFold predicted structures for essentially all 200 million known proteins and earned the 2024 Nobel Prize in Chemistry. Rentosertib became the first drug with an AI-discovered target and AI-designed molecule to improve lung function in a randomized, placebo-controlled Phase 2a trial (Nature Medicine). Autonomous "robot labs" like Lila Sciences ($1.3B valuation, backed by Nvidia) aim to run science at machine speed. The bottleneck in science is shifting from producing findings to verifying them — zero AI-discovered drugs have full FDA approval so far. No matter how fast discovery gets, your metabolic health remains the foundation AI can't replace. Studies & sources: Kobak et al. — Detecting AI fingerprints in biomedical abstracts (preprint) Nature News — AI-written biomedical literature Nobel Prize in Chemistry 2024 — AlphaFold Rentosertib Phase 2a randomized trial, Nature Medicine 2025 BBC News — Imperial College superbug question answered by AI in 2 days Fierce Biotech — Lila Sciences autonomous AI research labs Lila Sciences — $1.3B valuation with Nvidia backing CBS 60 Minutes — Demis Hassabis on "the end of disease" 📖 Dr. Lufkin's book "Lies I Taught in Medical School" ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Modern technology is tricking your nervous system into fight-or-flight — and it's decently profitable to keep you there. Jon Hacker, CEO of NeurGear, explains how focused ultrasound vagus nerve stimulation can switch you back. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with Jon Hacker, biomedical engineer and CEO/co-founder of NeurGear, the company behind ZenBud — the first ultrasound-based vagus nerve stimulator. They cover how the vagus nerve governs your rest-and-digest state, why so many of us are stuck in survival mode, how ultrasound compares to electrical stimulators, what the clinical trial data shows, and where single-neuron interfaces could take medicine next. Chapters: 00:00 — Introduction01:36 — From Anime Dream to Neurotech Startup: Jon Hacker's Story06:32 — How AI Supercharges a Small Hardware Team09:26 — Why Ultrasound Won: Two Pivots to the Vagus Nerve12:21 — Vagus Nerve 101: Rest-and-Digest vs Survival State14:59 — How Modern Technology Traps You in Fight-or-Flight16:02 — Measuring Vagal Tone: HRV, Resting Heart Rate & Reaction Time19:44 — How Focused Ultrasound Activates a Nerve21:07 — ZenBud vs Electrical Vagus Stimulators (Pulsetto, Truvaga)23:00 — Dosing ZenBud: 30-Minute Sessions, Sleep & Safety Limits26:05 — The Medical Industry's Incentive Problem30:16 — What to Track: Why Quality of Life Beats Biometrics32:34 — Side Effects & Overuse: Headache Warning Signs34:22 — Where VNS Fits: Sleep, Diet, Exercise & Breathwork36:57 — The Future: Single-Neuron Interfaces & Full-Dive VRKey takeaways: Your vagus nerve drives your "rest-and-digest" state — low vagal tone leaves you stuck in survival mode, and chronic survival-state activation feeds the chronic diseases we face todayZenBud uses low-intensity focused ultrasound (not electricity) to stimulate the auricular branch of the vagus nerve — no shocks, no gel pads, no app requiredIn a 4-week pilot trial, daily 5-minute sessions produced significant reductions in anxiety, depression, and PTSD symptom scoresReaction time, resting heart rate, and HRV can track nervous-system changes — but your quality of life is the gold standardStart with 5 minutes a day and scale up slowly; a mild reversible headache is the signal to dial backStudies & sources: Kohler I, Hacker J, Martin E — "Reduction of Anxiety-Related Symptoms Using Low-Intensity Focused Ultrasound Neuromodulation" (JMIR Neurotechnology, 2025) — https://neuro.jmir.org/2025/1/e69770Auricular Ultrasonic Vagus Nerve Stimulation (review, PMC) — https://pmc.ncbi.nlm.nih.gov/articles/PMC12468173/ZenBud device — https://zenbud.healthNeurGear — https://neurgear.com📖 Dr. Lufkin's book Lies I Taught in Medical School · 📰 Substack newsletter · 🌐 robertlufkinmd.com ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

For the first time in history, a personalized mRNA cancer vaccine has passed a Phase 3 clinical trial. Robert Lufkin MD breaks down the Moderna/Merck melanoma result, how a vaccine custom-built from your own tumor actually works, the 49% drop in recurrence risk behind the headlines — and the honest answer to whether mRNA vaccines will cure cancer. In this episode of Health Longevity Secrets, Robert Lufkin MD explains the science of personalized mRNA cancer vaccines: neoantigens, the AI-designed "most wanted poster" for your immune system, the five-year KEYNOTE-942 data, the stunning pancreatic cancer signal from Memorial Sloan Kettering, the BioNTech colorectal trial shutdown that reminds us why we run trials — and what still sits upstream of it all: your metabolic health. Chapters: 00:00 — Introduction: A Cancer Vaccine Makes History 00:43 — What Just Happened: Moderna/Merck Phase 3 Melanoma Trial 01:44 — A Vaccine Made From Your Own Tumor: How It Works 02:31 — Neoantigens: A "Most Wanted Poster" for Your T-Cells 03:17 — The Numbers Behind the Hype: 49% Lower Recurrence at 5 Years 03:53 — Pancreatic Cancer Vaccine: The Sloan Kettering Survival Signal 04:44 — So Will mRNA Vaccines Cure Cancer? The Honest Answer 05:40 — The Platform Play: Lung, Kidney & Prostate Cancer Trials 06:09 — The Honest Caveats: Press Releases vs Peer Review 06:45 — The Colorectal Trial Shutdown: A Reality Check 07:57 — The Takeaway: Metabolic Health Still Sits Upstream Key takeaways: Intismeran autogene + Keytruda is the first mRNA cancer vaccine to succeed in a Phase 3 trial — FDA approval possibly by early 2027. These are NOT prevention shots — each dose is custom-built from one patient's tumor mutations to hunt residual cancer cells after surgery. Five-year Phase 2b data (KEYNOTE-942): 49% lower risk of recurrence or death, and 62% lower risk of distant metastasis or death at three years. Pancreatic trial (n=16): ~90% of immune responders alive 4–6 years after surgery vs ~25% of non-responders — hypothesis-generating, not proof. The reality check: BioNTech/Genentech halted a colorectal Phase 2 after MORE deaths in the vaccine-alone arm — same technology, different cancer, opposite result. The Phase 3 result is a top-line press release, not yet peer-reviewed; the vaccine is not FDA-approved and is only available in clinical trials today. Muscle, blood sugar control, sleep, not smoking, and sun protection remain the most proven cancer-risk tools you own right now. Studies & sources: Merck/Moderna press release (Aug 19, 2026) — Phase 3 INTerpath-001: intismeran autogene + Keytruda met RFS & DMFS endpoints Nature news — Personalized Moderna/Merck mRNA vaccine reduces melanoma recurrence in Phase 3 Weber et al., J Clin Oncol 2026 — 5-Year Update of KEYNOTE-942 (49% recurrence/death reduction) Rojas et al., Nature 2023 — Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer (MSK) BioNTech statement (Aug 28, 2026) — Phase 2 colorectal trial of autogene cevumeran terminated ABC News — Personalized mRNA cancer vaccine shows promise Dr. Lufkin's book Lies I Taught in Medical School — more at robertlufkinmd.com and the Health Longevity Brief on Substack. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Neurologist David Perlmutter MD says the beta-amyloid theory of Alzheimer's is wrong — and the real culprit is your brain's own immune cells. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with the #1 New York Times bestselling author to unpack his new book Brain Defenders: how diet, blood sugar, and metabolic health flip the brain's microglia from protective to destructive, why anti-amyloid drugs offer "trivial" benefit, and which biomarkers actually predict your brain's future. Chapters: 00:00 — Introduction01:38 — Why He Left Mainstream Neurology to Prevent Brain Decline05:24 — Building the World's Largest Integrative Neurology Practice06:55 — The Common Pathway From Metabolism to Brain Degeneration08:25 — Why the Beta-Amyloid Theory of Alzheimer's Is Wrong09:11 — What Are Microglia? The Brain's Immune Cells (M1 vs M2)12:13 — From Brain "Glue" to Master Regulators of Your Synapses16:00 — How Body Inflammation and Cytokines Reach the Brain18:15 — Leaky Gut, the Microbiome, and Brain Degeneration19:46 — Ultra-Processed Foods Raise Alzheimer's Risk Up to 270%25:02 — Synaptic Pruning: The Link Between Autism, ADHD and Alzheimer's29:36 — Why Diabetics Recover Worse From Head Trauma31:51 — Anti-Amyloid Drugs: "Trivial" Benefit, Serious Harm35:37 — The Biomarkers to Track: Fasting Glucose, Insulin, A1C40:09 — On the Horizon: Mitochondrial Therapies and Microglial Transplants45:26 — Glyphosate, Air Pollution and 40Hz Light Therapy47:00 — Brain Defenders Releases August 18 — Final TakeawaysKey takeaways: Alzheimer's is increasingly understood as a "synaptopathy" — a disease of lost synapses driven by the brain's own immune cells (microglia), not simply beta-amyloid plaque.Microglia shift from supportive (M2) to destructive (M1) in response to metabolic signals: high blood sugar, insulin resistance, elevated blood pressure, excess body fat, and inflammation.A long-term cohort found each daily serving of ultra-processed food raised Alzheimer's risk ~13%, with 10+ servings/day linked to a 2.7-fold (270%) increase.A Cochrane review of anti-amyloid antibodies found "trivial" cognitive benefit alongside meaningful harm, including brain swelling and microbleeds (ARIA).The most actionable brain biomarkers are cheap and accessible: fasting glucose, fasting insulin, A1c, waist circumference, and a continuous glucose monitor — aim for optimal, not just "normal."Emerging frontiers target the mitochondria inside microglia — metformin, CoQ10, urolithin A, exercise, fasting, ketones, and 40Hz gamma light therapy.Studies & sources: Weinstein et al., J Prev Alzheimers Dis — ultra-processed food and Alzheimer's riskCochrane Review (2026) — anti-amyloid monoclonal antibodies for Alzheimer'sIaccarino, Tsai et al. (Tsai Lab, MIT) — 40Hz gamma light and microgliaDr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

They just injected youth genes into a human eye. On June 9, 2026, a patient with glaucoma became the first human ever dosed with ER-100 — an epigenetic reprogramming gene therapy designed not just to slow aging, but to reverse it. In this solo explainer, Dr. Robert Lufkin breaks down the science of partial cellular reprogramming, the Harvard study that restored vision in old mice, the built-in genetic safety switch, and what this first-in-human trial really means — and doesn't mean — for the future of longevity. Chapters 00:00 — Introduction: Youth Genes Injected Into a Human Eye00:41 — Glaucoma: Blindness That Only Moves in One Direction01:42 — The Harvard Mice That Got Their Vision Back02:05 — Yamanaka Factors and the OSK Gene Cocktail03:08 — June 9, 2026: First Human Dosed With ER-10003:54 — The Doxycycline Safety Switch Built Into the Genes04:35 — Aging as Lost Information: Hardware vs Software05:27 — Why Scientists Chose the Eye First06:05 — The Honest Caveat: Phase 1 Means Safety, Not Efficacy07:13 — The Takeaway: What Already Works for LongevityStudies & sources mentioned Lu et al. 2020, Nature — OSK reprogramming restored vision in old mice: https://pubmed.ncbi.nlm.nih.gov/33268865/Tham et al. 2014, Ophthalmology — global glaucoma prevalence: https://pubmed.ncbi.nlm.nih.gov/24974815/Life Biosciences — first patient dosed in Phase 1 trial of ER-100: https://www.globenewswire.com/news-release/2026/06/09/3308634/0/en/life-biosciences-announces-first-patient-dosed-in-phase-1-trial-of-er-100-for-optic-neuropathies.htmlTrial registration (NCT07290244): https://clinicaltrials.gov/study/NCT07290244⚠️ Honest caveat: this is a Phase 1, open-label safety trial in roughly 18 adults. The primary endpoint is safety and tolerability — not vision restoration. Nothing here is medical advice; this content is for educational purposes only. 📕 Book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ 📰 Weekly newsletter: https://robertlufkinmd.substack.com 🌐 Website: https://robertlufkinmd.com ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

What if your genes aren't your destiny? Cell biologist Bruce Lipton PhD — the former medical school professor whose cloned stem cell research helped pioneer epigenetics, and author of The Biology of Belief (published in over 50 languages) — joins Robert Lufkin MD to make the case that perception, not DNA, controls your biology. A positive belief can heal (the placebo effect); a negative belief can harm (the nocebo effect) — which is why Bruce calls a prognosis a prescription. And now, after a cancer diagnosis at 80, he is living his science in the most personal way imaginable. His new book, Beyond Darwin: How Epigenetics, Quantum Science, and Cooperation Shape Humanity's Future, releases today — the same day as this episode. Chapters: 00:00 — Introduction02:36 — The Stem Cell Experiment That Broke the Dogma05:55 — Epigenetics: Control Above the Gene09:12 — The Brain Is the Chemist: Beliefs Become Biology12:04 — Cancer Is Not Genetic: The Adoptee Data20:43 — Placebo and Its Dark Twin, the Nocebo23:34 — Prognosis as Prescription: Delivering a Diagnosis30:36 — Stem Cells: Your Built-In Repair System32:46 — Bruce's Cancer at 80 and the Younger Doctors40:16 — Programmed in the First Seven Years44:05 — Conscious vs Subconscious: The 95% Problem48:34 — The Matrix, the Red Pill, and Falling in Love50:55 — Why Marriages Fall Apart: Living From the Program55:54 — A New Generation of Medicine57:53 — Civilization's Programming and Conscious EvolutionKey takeaways: Genetically identical stem cells became muscle, bone, or fat depending only on their environment — the culture medium, not the genes, determined their fate.Fewer than 1% of diseases are caused by genes alone; adoption studies show adoptees acquire the disease patterns of their adoptive families, not their biological ones.The brain is the chemist: perception shapes blood chemistry, which controls gene expression.Placebo beliefs can heal — and nocebo beliefs can harm. A substantial share of treatment outcomes reflects belief effects.Your body replaces roughly 3.5 million cells every second, powered by stem cells — your built-in repair system.About 95% of daily behavior runs on subconscious programs downloaded in the first seven years of life.Change the program — through mindfulness, presence, and repetition — and you change your biology.Studies & sources: Sørensen et al., NEJM 1988 — premature death in adoptees tracks adoptive, not biological, parents: https://pubmed.ncbi.nlm.nih.gov/3347221/Rooney et al., Health Psychology 2024 — meta-analysis of nocebo effects: https://pubmed.ncbi.nlm.nih.gov/37843534/Colloca & Miller 2011 — the nocebo effect and its clinical relevance: https://pmc.ncbi.nlm.nih.gov/articles/PMC3167012/Kaptchuk & Miller, NEJM 2015 — placebo effects in medicine: https://www.nejm.org/doi/10.1056/NEJMp1504023Motesharrei et al., Ecological Economics 2014 — the NASA-funded HANDY model on societal sustainability: https://nature.berkeley.edu/garbelottoat/wp-content/uploads/motesharrei-etat-2014.pdfBruce Lipton's new book, Beyond Darwin (BenBella): https://benbellabooks.com/shop/beyond-darwin/Watch the full episode on YouTube: https://youtu.be/6BnJVoo_iXs Robert Lufkin MD's book, Lies I Taught in Medical School: https://robertlufkinmd.com/lies/  Newsletter: https://robertlufkinmd.substack.com  Website: https://robertlufkinmd.com The information provided in this program is for general informational purposes only and is not intended as a substitute for professional medical advice. Always consult your physician regarding your personal health decisions. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

A healthy 27-year-old walked into a Bronx wellness center for an NAD+ "longevity infusion" — and was dead within the hour. The man holding the needle wasn't licensed to practice medicine anywhere in the US. Robert Lufkin MD breaks down the Elizabeth Baron case: what actually happened, what NAD+ can and can't do based on the real evidence, why the billion-dollar med spa industry operates like the Wild West, and the three-license checklist that can protect you before anyone puts a needle in your arm. Chapters: 00:00 — Introduction: Death After an Anti-Aging IV Drip00:44 — What Happened in the Bronx: The Elizabeth Baron Case01:58 — What's Actually in the Bag: NAD+ Explained02:56 — No Randomized Trial Evidence for IV NAD+03:38 — The Wild West: Inside the Unregulated Med Spa Boom04:02 — A Pattern of Med Spa Deaths and Injuries04:54 — The Three Licenses: Person, Building, Bottle06:19 — The Honest Caveat: Cause of Death Still Pending07:17 — The Takeaway: Fundamentals Beat the DripKey takeaways: NAD+ is real biology — a coenzyme central to energy production and DNA repair — but no randomized trial has ever shown an IV NAD+ drip slows aging in humans.IV NAD+ is legal yet not FDA approved for any specific application, and the marketing has sprinted far ahead of the evidence.An IV bypasses every natural checkpoint in your body. Treat it like surgery on your blood.Before any injection or infusion, verify three licenses: the person, the building, and the bottle. If a clinic can't answer instantly, walk out.The fundamentals that actually move healthspan — muscle, metabolic health, sleep, blood pressure, blood sugar — cost almost nothing and have mountains of evidence.Sources & reporting: NY Daily News — Bronx clinic death and arrestNY Post — arraignment coverageArina Cadariu MD, MPH — "Nobody Is Counting"NY Post — inside the unregulated med spa industryNewser — case roundupCBS News New York — the three licenses📖 Dr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ 📰 Substack newsletter: https://robertlufkinmd.substack.com 🌐 Website: https://robertlufkinmd.com This episode is educational content only and is not medical advice. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

A cardiac surgeon who's performed thousands of open-heart operations says most of his patients didn't have to be there — and the culprit isn't cholesterol, it's metabolic health. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with Dr. Philip Ovadia, board-certified cardiac surgeon and author of the new book "Stay Off My Kitchen Table." Once morbidly obese and prediabetic himself, Ovadia lost nearly 100 pounds and rethought everything he was taught about heart disease. He explains why "meat is medicine," how red meat got vilified by bad science, what really drives heart disease, and how his nationwide telehealth practice is rebuilding primary care around metabolic health. Chapters: 00:00 — Introduction01:34 — Why a Heart Surgeon Wrote "Stay Off My Kitchen Table"04:54 — Do You Need to Eat Meat? Nutrient Density and Bioavailability07:30 — Meat Is Medicine: Why Red Meat Was Vilified09:38 — How Bad Epidemiology Made Meat the Villain12:43 — Red Meat Down 40%, Heart Disease Worse: What That Tells Us14:23 — Ovadia's Own Journey: Obese, Prediabetic, and Gary Taubes15:54 — Why Medical Schools Resist This (and What's Changing)19:01 — RFK Jr, Trump, the New Food Pyramid and realfood.gov21:38 — Leaving Employed Surgery for a Telehealth Practice25:24 — Metabolic Care Beyond the Heart: Building Primary Care31:38 — What Telemedicine Patients Actually Experience37:01 — It's Not Just What You Eat — It's What You Absorb38:50 — Gut Health, Anti-Nutrients, and the NAD Supplement Problem42:37 — Best Wearables: Why the CGM Tops the List44:11 — Empowering Patients to Take Back ControlKey takeaways: Metabolic health — not cholesterol — is the primary driver of heart disease, and most heart surgery is preventable through diet and lifestyle."Meat is medicine": red meat was vilified largely by poorly done epidemiologic science layered with political and economic interests.U.S. red meat consumption has fallen ~40% since the 1950s–60s, yet heart disease has gotten worse — strong evidence meat isn't the cause.It's not just what you eat, it's what you absorb: gut health, bioavailability, and plant anti-nutrients all shape your results.The continuous glucose monitor (CGM) is the single most powerful wearable for understanding how food and lifestyle affect your metabolic health.Studies & sources: "Stay Off My Kitchen Table" by Dr. Philip Ovadia (with Joshua Lisik) — ovadiahearthealth.com"Stay Off My Operating Table" by Dr. Philip Ovadia — GoodreadsOvadia Heart Health (nationwide telehealth practice) — ovadiahearthealth.comNew U.S. dietary guidelines & food pyramid — realfood.govGary Taubes (author and science journalist) — garytaubes.comDr. Lufkin's book "Lies I Taught in Medical School": robertlufkinmd.com/lies ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

"There's no such thing as a weight problem — it's a weight symptom." Ben Azadi joins Robert Lufkin MD to dismantle the calorie myth and reveal the metabolic root cause underneath stubborn fat, fatigue, and disease. Ben Azadi — functional health practitioner, founder of Keto Camp, and bestselling author of "Metabolic Freedom" — unpacks metabolic flexibility, diet variation, fasting, and why staying in ketosis forever can backfire. He previews his revised book "Keto Flex" (out July 21) and shares how he lost 80 pounds and rebuilt his metabolism from the inside out. Chapters: 00:00 — Introduction01:30 — Ben Azadi's 80-Pound Transformation Story03:00 — What Was Actually Broken in His Metabolism06:00 — "You Don't Have a Weight Problem, You Have a Weight Symptom"07:30 — The 3 Percenters: Why 97% Chase Symptoms08:30 — Ask the Right Question: How Do I Lower Insulin?09:30 — Diet Variation: Why Cycling In and Out of Ketosis Works Better12:00 — Feast Day vs Cheat Day: Flexing to Healthy Carbs13:30 — Warning Signs You've Stayed in Keto Too Long15:00 — Hormesis, Stress, and the Post-Menopause Caveat16:30 — Using Heart Rate Variability to Dial In Your Stressors18:00 — The Carnivore "Toxin Terminator" and Plant Compounds22:30 — Chapter 9: A Customized Keto Plan for Women25:30 — Fasting, Autophagy, and mTOR Balance28:30 — How a 48-Hour Fast Resensitizes Your Dopamine Receptors30:00 — Where People Get Fasting Wrong (Don't Forget to Feast)33:00 — Metrics That Track Real Progress (Glucose, CGM, Oura)34:30 — AI, Wearables, and the End of One-Size-Fits-All Diets37:30 — What's New in the Revised Keto Flex40:30 — Metabolic Freedom vs Keto Flex: Which Book First?42:00 — Final Message: Identify the Interference, Let the Body HealKey takeaways: Weight is a symptom, not the problem — chase the root cause (insulin, inflammation, hormones), not the number on the scale.Metabolic flexibility beats rigid dieting: cycling in and out of ketosis with feast days keeps the body adaptive.Staying in ketosis indefinitely can backfire — watch for warning signs and build in strategic carb refeeds.Hormetic stressors (fasting, cold, exercise) help — but dose them to your recovery, tracked via HRV and tools like the Oura ring.A 48-hour fast can resensitize dopamine D2 receptors and reset reward signaling.Women often need a cyclical, customized keto approach — one-size-fits-all fails.Studies & sources: Fasting and dopamine D2 receptor availability — Dunn et al., Diabetes Care 2012 — diabetesjournals.orgKetogenic diet raises glutathione (hormesis / antioxidant defense) — Napolitano et al., Metabolites 2020 — pmc.ncbi.nlm.nih.govBen Azadi's revised book "Keto Flex" (bonuses) — ketoflexbook.comDr. Lufkin's book "Lies I Taught in Medical School": robertlufkinmd.com/lies ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

What if a single nerve in your ear could shift you out of fight-or-flight in 10 minutes? Jane Ollis explains why your vagus nerve and HRV may be the most overlooked levers for stress, sleep, and longevity. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with Jane Ollis — founder and CEO of Sona, medical biochemist with a career across NASA, Oxford, and the NHS — to unpack the science of the vagus nerve, heart rate variability (HRV), and the autonomic nervous system. Jane breaks down why HRV is one of the strongest predictors of all-cause mortality, why a tiny patch of "fish gill pipework" in your outer ear is the key to calm, and how Sona's AI-powered closed-loop vagus nerve stimulator personalizes a 10-minute daily protocol to retrain a nervous system stuck in chronic sympathetic overdrive. CHAPTERS: 00:00 — Introduction 01:01 — Meet Jane Ollis: From NASA and Oxford to Vagus Nerve Science 03:05 — Why Chronic Stress Drives Inflammation, Insulin Resistance and Disease 05:07 — Sympathetic vs Parasympathetic: The Two Arms of Your Autonomic Nervous System 08:09 — The Hidden Benefit of Stress (And Why You Still Need Recovery) 11:13 — Cortisol, Adrenaline and How the Stress Response Actually Works 12:14 — Acetylcholine, Repair Mode and the Parasympathetic Switch 14:19 — Symptoms of Autonomic Imbalance and Sympathetic Overdrive 17:22 — Heart Rate Variability: Why It Predicts All-Cause Mortality 20:27 — HRV, Aging, Blood Pressure and the Baroreceptor Connection 23:29 — Anatomy of the Vagus Nerve: The Body's Communication Superhighway 26:33 — Free Vagus Nerve Hacks: Slow Breathing, Humming and Chanting 28:35 — How Vagus Nerve Stimulation Works (Cervical vs Auricular Branch) 30:37 — From Epilepsy to Depression: 30 Years of Implanted VNS Research 32:40 — Inside Sona: The First AI-Powered Closed-Loop Vagus Nerve Stimulator 35:44 — How to Use Sona: 10-Minute Daily Sleep Ritual and Neuroplasticity Stack 38:46 — Sleep Quality, Deep Sleep and Stroke Rehab: What the VNS Evidence Shows 40:49 — The Future: Personalized VNS for Anxiety, PTSD, Long COVID and Metabolic Disease 42:52 — The Biggest Myth About Stress, Recovery and Resilience 45:00 — Final Takeaway: One Small Action to Calm Your Nervous System Today KEY TAKEAWAYS: Higher heart rate variability (HRV) is one of the strongest non-invasive predictors of all-cause and cardiovascular mortality. The parasympathetic nervous system isn't about "switching off" — it switches on repair, digestion, and immune housekeeping via acetylcholine. 80% of vagus nerve fibers carry information from the body to the brain — it's a communication highway, not just an output. The auricular branch of the vagus nerve in the outer ear (cymba conchae) is a 100% afferent vagal pathway. Slow-paced breathing with a long nasal exhale, humming, and chanting are zero-cost vagal activation tools that raise HRV. Closed-loop, AI-personalized vagal stimulation may unlock applications in anxiety, depression, PTSD, long COVID, and metabolic disease. STUDIES & SOURCES: Sammito et al., 2022 — HRV as a predictor of all-cause mortality: https://pubmed.ncbi.nlm.nih.gov/36243195/ Wang et al., 2023 — taVNS in depression meta-analysis: https://pubmed.ncbi.nlm.nih.gov/37230264/ Wu et al., 2018 — taVNS for depression: Frontiers in Psychiatry taVNS for insomnia (PSQI): ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

The same glucosamine pill millions take for joint pain may protect a healthy brain — and accelerate Alzheimer's in a brain already in decline. Here's the science. In this episode of Health Longevity Secrets, Robert Lufkin MD breaks down the 2026 plot twist on glucosamine and dementia: why a supplement once hailed as a longevity hack now carries an Alzheimer's warning, and why the answer comes down to one thing — the state of your metabolism. The same molecule helped the metabolically healthy and may have harmed the metabolically broken. The supplement didn't change; the soil it landed on did. Chapters: 00:00 — Introduction00:39 — The Supplement Everyone Trusted01:06 — UK Biobank: Glucosamine and 15% Lower Death Risk01:38 — Why Glucosamine Looked Like a Longevity Hack02:48 — The 2026 Plot Twist: Nature Metabolism Study03:53 — Alzheimer's Mice and the Glucosamine Pathway04:13 — How Sugar Tagging (Glycosylation) Explains Both04:57 — Hyperglycosylation in the Alzheimer's Brain05:34 — The Honest Caveat: Association vs Causation06:55 — The Takeaway: Metabolic Health Decides EverythingKey takeaways: In healthy, cognitively normal adults, regular glucosamine use has been tied to lower all-cause mortality and lower risk of dementia — especially vascular dementia.A June 2026 University of Florida study in Nature Metabolism found the opposite signal in sick brains: in people with mild cognitive impairment, glucosamine use was associated with a 25% higher likelihood of progressing to Alzheimer's, and a 25% higher death risk in those already diagnosed.In Alzheimer's mice, glucosamine made memory worse; blocking the same sugar-tagging pathway made it better.The mechanism is metabolic: glucosamine feeds glycosylation (sugar-tagging of proteins). A healthy brain handles it fine; an Alzheimer's brain is already hyperglycosylated, so adding more is "pouring gasoline on the fire."This is association, not proof of cause — and the literature is genuinely mixed. If you're healthy, it's not a fire alarm. If you or a loved one has MCI or dementia, talk to your physician before the next refill.Studies & sources: Hawkinson et al., "Hyperglycosylation is a metabolic driver of Alzheimer's disease," Nature Metabolism 2026 (University of Florida)University of Florida news release on the glucosamine–dementia findingZheng et al., "Association of regular glucosamine use with incident dementia," BMC Medicine 2023 (UK Biobank)Habitual glucosamine use, APOE genotypes, and cause-specific dementia in older adults (UK Biobank)Li et al., "Associations of regular glucosamine use with all-cause and cause-specific mortality," Annals of the Rheumatic Diseases 2020 (UK Biobank)Read Dr. Lufkin's book "Lies I Taught in Medical School". ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/